About the Authors
- De-Hyung Lee
-
* E-mail: de-hyung.lee@uk-erlangen.de
Affiliation Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Silvia Seubert
-
Affiliation Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Konstantin Huhn
-
Affiliation Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Lukas Brecht
-
Affiliation Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Caroline Rötger
-
Affiliation Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Anne Waschbisch
-
Affiliation Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Johannes Schlachetzki
-
Affiliation Department of Molecular Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Alice Klausmeyer
-
Affiliation Institute of Molecular Neurobiology, Ruhr-University, Bochum, Germany
- Arthur Melms
-
Affiliation Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Stefan Wiese
-
Affiliation Institute of Molecular Neurobiology, Ruhr-University, Bochum, Germany
- Jürgen Winkler
-
Affiliation Department of Molecular Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
- Ralf A. Linker
-
Affiliation Department of Neurology, Friedrich-Alexander-University, Erlangen-Nuremberg, Germany
Competing Interests
Fingolimod is a product of Novartis. There are no other patents, products in development or marketed products to declare. This does not alter our adherence to all the PLOS ONE policies on sharing data and materials.
Author Contributions
Conceptualization: D-HL AM AW SW JW RAL. Formal analysis: D-HL KH LB CR JS AK RAL. Funding acquisition: SW JW RAL. Investigation: D-HL SS KH LB CR AK. Methodology: D-HL SS SW JW RAL. Project administration: D-HL RAL. Resources: JS AK AM SW JW. Supervision: D-HL AM SW JW RAL. Validation: D-HL SS AK. Visualization: D-HL RAL. Writing – original draft: D-HL SS AW JS SW JW RAL. Writing – review & editing: D-HL RAL.